Trial Profile
Phase I trial of oral CR 845 for neuropathic pain.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 09 Mar 2012
Price :
$35
*
At a glance
- Drugs Difelikefalin (Primary)
- Indications Neuropathic pain
- Focus Adverse reactions
- Sponsors Cara Therapeutics
- 09 Mar 2012 New trial record